146 related articles for article (PubMed ID: 12005258)
21. ICV administration of anti-NPY antisense oligonucleotide: effects on feeding behavior, body weight, peptide content and peptide release.
Hulsey MG; Pless CM; White BD; Martin RJ
Regul Pept; 1995 Oct; 59(2):207-14. PubMed ID: 8584756
[TBL] [Abstract][Full Text] [Related]
22. Central dopamine action modulates neuropeptide-controlled appetite via the hypothalamic PI3K/NF-κB-dependent mechanism.
Hsieh YS; Chen PN; Yu CH; Kuo DY
Genes Brain Behav; 2014 Nov; 13(8):784-93. PubMed ID: 25160767
[TBL] [Abstract][Full Text] [Related]
23. Transcript of protein kinase A knock-down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats.
Hsieh YS; Yang SF; Chu SC; Kuo DY
Physiol Genomics; 2007 Oct; 31(2):306-14. PubMed ID: 17684035
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides.
Schaffhauser AO; Stricker-Krongrad A; Brunner L; Cumin F; Gerald C; Whitebread S; Criscione L; Hofbauer KG
Diabetes; 1997 Nov; 46(11):1792-8. PubMed ID: 9356028
[TBL] [Abstract][Full Text] [Related]
25. Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake.
Gillard ER; Dang DQ; Stanley BG
Brain Res; 1993 Nov; 628(1-2):128-36. PubMed ID: 8313139
[TBL] [Abstract][Full Text] [Related]
26. Hypothalamic neuropeptide Y (NPY) and the attenuation of hyperphagia in streptozotocin diabetic rats treated with dopamine D1/D2 agonists.
Kuo DY
Br J Pharmacol; 2006 Jul; 148(5):640-7. PubMed ID: 16702993
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional involvement of protein kinase C-alpha isozyme in amphetamine-mediated appetite suppression.
Hsieh YS; Yang SF; Chiou HL; Kuo DY
Eur J Neurosci; 2005 Aug; 22(3):715-23. PubMed ID: 16101753
[TBL] [Abstract][Full Text] [Related]
28. Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine.
Dryden S; Frankish HM; Wang Q; Williams G
Brain Res; 1996 Jun; 724(2):232-7. PubMed ID: 8828573
[TBL] [Abstract][Full Text] [Related]
29. Amphetamine-induced effects on neuropeptide Y in the rat brain.
Obuchowicz E; Turchan J; Przewłocki R; Herman ZS
Pharmacol Rep; 2005; 57(3):321-9. PubMed ID: 15985714
[TBL] [Abstract][Full Text] [Related]
30. Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion.
Akabayashi A; Wahlestedt C; Alexander JT; Leibowitz SF
Brain Res Mol Brain Res; 1994 Jan; 21(1-2):55-61. PubMed ID: 8164522
[TBL] [Abstract][Full Text] [Related]
31. Neuropeptide Y counteracts the anorectic and weight reducing effects of ciliary neurotropic factor.
Pu S; Dhillon H; Moldawer LL; Kalra PS; Kalra SP
J Neuroendocrinol; 2000 Sep; 12(9):827-32. PubMed ID: 10971807
[TBL] [Abstract][Full Text] [Related]
32. Role of hypothalamic neuropeptide Y and orexigenic peptides in anorexia associated with experimental colitis in the rat.
Ballinger AB; Williams G; Corder R; El-Haj T; Farthing MJ
Clin Sci (Lond); 2001 Feb; 100(2):221-9. PubMed ID: 11171292
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of the transcript of ERK in the brain modulates hypothalamic neuropeptide-mediated appetite control in amphetamine-treated rats.
Yu CH; Hsieh YS; Chen PN; Chen JR; Kuo DY
Br J Pharmacol; 2018 Feb; 175(4):726-739. PubMed ID: 29215157
[TBL] [Abstract][Full Text] [Related]
34. Role of oxidative stress in disrupting the function of negative glucocorticoid response element in daily amphetamine-treated rats.
Chu SC; Yu CH; Chen PN; Hsieh YS; Kuo DY
Psychoneuroendocrinology; 2016 Sep; 71():1-11. PubMed ID: 27235634
[TBL] [Abstract][Full Text] [Related]
35. Interrupting activator protein-1 signaling in conscious rats can modify neuropeptide Y gene expression and feeding behavior of phenylpropanolamine.
Hsieh YS; Yang SF; Chu SC; Kuo DY
J Neurochem; 2008 Jan; 104(1):50-61. PubMed ID: 17868324
[TBL] [Abstract][Full Text] [Related]
36. Hypothalamic circuitry of neuropeptide Y regulation of neuroendocrine function and food intake via the Y5 receptor subtype.
Campbell RE; ffrench-Mullen JM; Cowley MA; Smith MS; Grove KL
Neuroendocrinology; 2001 Aug; 74(2):106-19. PubMed ID: 11474218
[TBL] [Abstract][Full Text] [Related]
37. Assessment of feeding response of tumor-bearing rats to hypothalamic injection and infusion of neuropeptide Y.
Chance WT; Balasubramaniam A; Thompson H; Mohapatra B; Ramo J; Fischer JE
Peptides; 1996; 17(5):797-801. PubMed ID: 8844769
[TBL] [Abstract][Full Text] [Related]
38. Involvement of hypothalamic PI3K-STAT3 signalling in regulating appetite suppression mediated by amphetamine.
Chu SC; Chen PN; Hsieh YS; Yu CH; Lin MH; Lin YH; Kuo DY
Br J Pharmacol; 2014 Jul; 171(13):3223-33. PubMed ID: 24597972
[TBL] [Abstract][Full Text] [Related]
39. Evidence for the involvement of dopamine D(1) and D(2) receptors in mediating the decrease of food intake during repeated treatment with amphetamine.
Chen TY; Duh SL; Huang CC; Lin TB; Kuo DY
J Biomed Sci; 2001; 8(6):462-6. PubMed ID: 11702009
[TBL] [Abstract][Full Text] [Related]
40. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat.
Wang Q; Bing C; Al-Barazanji K; Mossakowaska DE; Wang XM; McBay DL; Neville WA; Taddayon M; Pickavance L; Dryden S; Thomas ME; McHale MT; Gloyer IS; Wilson S; Buckingham R; Arch JR; Trayhurn P; Williams G
Diabetes; 1997 Mar; 46(3):335-41. PubMed ID: 9032086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
